HPQ
37
2
IBM
62
-3
HRL
30
-5
SE
43
3
MMM
54
-3
BDX
60
-4
EMR
64
-3
AEP
59
-5
TJX
64
-2
TRV
48
-10
FLR
40
-2
DVN
39
-4
KIM
51
-3
CF
42
-6
D
43
-2
LOW
46
-3
XYL
27
-2
CA
27
9
RIG
35
-6
PX
62
6
HPQ
37
2
IBM
62
-3
HRL
30
-5
SE
43
3
MMM
54
-3
BDX
60
-4
EMR
64
-3
AEP
59
-5
TJX
64
-2
TRV
48
-10
FLR
40
-2
DVN
39
-4
KIM
51
-3
CF
42
-6
D
43
-2
LOW
46
-3
XYL
27
-2
CA
27
9
RIG
35
-6
PX
62
6
Financhill
Back

Nuveen Credit Strategies Income Fund Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Buy
59

JQC
Nuveen Credit Strategies Income Fund

Last Price:
$4.99
Seasonality Move:
0.94%
Buy
64

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$89.21
Seasonality Move:
-30.03%
Buy
59
Nuveen Credit Strategies Income Fund (JQC) is a Buy

Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?

  • The current Nuveen Credit Strategies Income Fund [JQC] share price is $5.00. The Score for JQC is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • JQC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $93.99. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

JQC Stock Price Chart

What is Nuveen Credit Strategies Income Fund's stock price today?

  • The Nuveen Credit Strategies Income Fund share price today is $5.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JQC is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $93.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

JQC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 38.68 Sell
Chaikin Money Flow: 242453 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.78 Buy
Relative Strength Index (14 RSI): 76.13 Buy
Chaikin Money Flow: 147064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.66 - 81.44) Buy
Bollinger Bands (100): (40.97 - 68.09) Buy

JQC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.04 Sell
20-day SMA: 5.04 Sell
50-day SMA: 5.08 Sell
200-day SMA: 5.29 Sell
8-day EMA: 5.04 Sell
20-day EMA: 5.05 Sell
50-day EMA: 5.11 Sell
200-day EMA: 5.3 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.53 Buy
20-day SMA: 72.88 Buy
50-day SMA: 64.83 Buy
200-day SMA: 42.54 Buy
8-day EMA: 84.37 Buy
20-day EMA: 75.93 Buy
50-day EMA: 66.06 Buy
200-day EMA: 46.89 Buy

Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

Nuveen Credit Strategies Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):